Top member reports
No meetings
Consensus community valuation
The consensus valuation is for members only and has been removed from this chart. Click for membership options.
Contributing Members
Content is delayed by one month. Upgrade your membership to unlock all content. Click for membership options.
#Time to sell???
stale
Last edited 12 months ago

Hello all,

Any thoughts regarding MPL. I've been a RL shareholder since the IPO and according to sharesight it has returned over 17% p.a over that time. A surprisingly good return given the sector it is in. My instinct suggests it is unlikely to continue to post such good returns in the future. It is more likely to stagnant and provide modest but reasonable safe returns in the medium term.

The original purchasing thesis was built upon two concepts. Firstly, the government usually sell off good assets too cheaply. Secondly, the government can't afford to let private health insurers fail, as this would present a massive challenge to the already stretch public health system.

Continuing to hold in RL no longer fits into my investing style, but I am struggling to hit the sell button. It provides exposure to the health sector and is very likely to exist and be bigger in the future, especially if we continue super high levels of immigration.

Any thoughts good people of Strawland?

Read More
#Risks
stale
Added 2 years ago

Medibank down 18% on further details of hack impacting nearly, if not, every customer past and present.

There is still the question of who and when the person responsible will be caught - of course that will be confidential.

A fairly serious data breach with at least the date of birth and medicare number details leaked, would be interesting to see how the criminal was able to obtain so much personal data.

Read More
# Policyholders & Portfolio
stale
Added 2 years ago

Policy holders growth a slim circa 2%pa MPL Investment Portfolio: composition


9ed8d53d3d7b893e8335acef8711121bdb15c6.png

Read More
Valuation of $3.60
stale
Added 2 years ago

Profitable as displayed by the ROE

Gross divi yield: Latest 5.28% ,, outlook circa 5.28% , 5.90%

EPS latest 15.20cps , projected EPS17.60cps

Looking ahead, management has not provided FY23 earnings guidance but points to a 2.7% growth in policyholders. Consensus is anticipating earnings growth of 15.8% while dividends are expected to increase by 13.1% to 14.7cps, fully funded from projected cash earnings 

SO a steady stock, Park the cash here get the dividend along with some capital growth.



Read More
#FY22, results
stale
Added 2 years ago

Strong result reflects growth across our business alongside ongoing cost discipline

FY23, Some policy growth expected

Final dividend 7.3cps Fully Franked

2924-02554522-3A599338 (markitdigital.com)

4462f658593006b56c2ee2867c37bffe62b59f.png


1c392d32fb5c3867775c3d2a181a790353f2e2.png


Read More